摘要
目的探讨原发性肝癌伴门脉主干癌栓介入治疗的理想方案。方法采用经肝动脉化疗栓塞术(TACE)联合门脉支架+125I粒子条植入、胆道支架+125I粒子条植入、内镜下曲张静脉套扎术三阶段治疗方法,治疗1例原发性肝癌伴门脉主干癌栓患者,并结合文献复习,比较目前各种介入治疗方案的疗效差异。结果三阶段治疗方案均成功实施,目前患者随访超5年,仍存活良好。结论 TACE联合门脉支架+125I粒子条植入术为目前原发性肝癌伴门脉主干癌栓介入治疗的最佳方案。
Objective To investigate the optimal interventional therapy for primary hepatocellular carcinoma（HCC） complicated by main portal vein tumor thrombus. Methods Three- stage treatment, i.e.transcatheter arterial chemoembolization（TACE） combined with portal vein stenting and ^125I seeds strand implantation, biliary stenting plus125 I seeds strand implantation and endoscopic variceal ligation, was carried out in one patient with primary HCC complicated by main portal vein tumor thrombus. The clinical results were analyzed combined with a review of the relevant literature in order to compare the efficacies of various interventional therapies employed in clinical practice nowadays. Results The sequential therapies of the three- stage treatment program were successfully accomplished. The patient was followed up for over five years and lived well when the report was made. Conclusion At present, TACE combined with portal vein stenting and implantation of ^125 I seeds strand is the optimal treatment for primary HCC associated with portal vein tumor thrombus.
出处
《介入放射学杂志》
CSCD
北大核心
2015年第12期1101-1106,共6页
Journal of Interventional Radiology
基金
上海市卫计委先进适宜技术推广项目(2013SY060)
浙江省台州市科技计划项目(1402ky19)
台州学院培育基金(2014PY054)
关键词
癌
肝细胞
门静脉
癌栓
支架
碘125粒子
carcinoma
hepatocellular
portal vein
tumor thrombus
stent
125I seed
